Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating cognitive deficits in a subject having schizophrenia, bipolar disorder, or psychiatric depression, and exhibiting cognitive deficits by administering an antagonist of the Na+-K+-2Cl-cation-chloride cotransporter isoform 1 (NKCC1)

Methods for treating cognitive deficits in a subject having schizophrenia, bipolar disorder, or psychiatric depression, and exhibiting cognitive deficits by administering an antagonist of the Na+-K+-2Cl-cation-chloride cotransporter isoform 1 (NKCC1)

US Patent 11666547 · Granted Jun 6, 2023

Estimated economic value: $101,565,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compound for the determination of the protein FKBP12 and a sensor unit comprisin2025
Methods, kits, and devices for diagnosing, prognosing, and treating psychiatric 2025
Beta-carbolines as positive allosteric modulators of the human serotonin recepto2022
Methods, kits, and devices utilizing HTR2C polymorphisms for diagnosing, prognos2021
Enantioselective syntheses of heteroyohimbine natural product intermediates2020
Enantioselective syntheses of heteroyohimbine natural product intermediates2019
Methods of administering a trace amine-associated receptor 1 (TAAR1) agonist to 2018
Method for treating schizophrenia and related diseases2014
Screening method for controlling agranulocytosis1994
Method of treating therapy resistant schizophrenia with melperone (R-fluoro-Y-me1993